Acerus Pharmaceuticals

Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the development, manufacture, marketing, and distribution of innovative branded products that improve patient experience, primarily in the fields of men's and women's health. Acerus currently has three marketed products: ESTRACE®, a product for the relief of menopausal symptoms; NATESTO®, the first and only testosterone nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; URIVARX®, a natural health product that helps reduce symptoms of overactive bladder such as daytime urinary frequency, urgency, and nocturia.